Cytotoxic studies of anti-neoplastic drugs on human lymphocytes - In vitro studies

Cancer Biomarkers

Volumn 5, Issue 6, 2009, Pages 261-272

  Krishna, I Vamshi ^a   Vanaja, G R ^a   Kumar, N Srihari Kirmani ^b   Suman, G ^b  

^a UNIVERSITY OF MYSORE   (India)

^b Indo American Cancer Institute and Research Centre   (India)

Author keywords

Anti cancer drugs; Cytotoxicity; In vitro assays; MTT assay

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARBOPLATIN; GEMCITABINE; METHOTREXATE; NAVELBINE; PACLITAXEL; TAMOXIFEN;

ARTICLE; CELL ASSAY; CELL ISOLATION; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DONOR; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; SPECTROMETRY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELLS, CULTURED; HUMANS; LYMPHOCYTES; SPECTROPHOTOMETRY;

EID: 76749105284     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0111     Document Type: Article

References (28)

1. C.E. Ophardt Virtual Chembook, Elmhurst College, 2003.
2. E.E.Vokes and H.M. Golomb, Oncologic therapies. Published by Springer. ISBN 3540434615, 9783540434610. 659 (2003), 19.
3. T. Hampton and Promiscuous, Anticancer drugs that hit multiple targets may thwart resistance, JAMA 292 (2004), 419-420.
4. J.A. Hickman, Apoptosis induced by anticancer drugs, Cancer Metastasis Rev 11 (19), 121-139.
5. H.J. Mackay and C.J. Twelves, Department of Medical Oncology, Cancer Research UK, 2003.
6. Beatson Laboratories, Alexander Stone Building, Switchback Road, Glasgow G61 1BD, UK. REVIEW Endocrine-Related Cancer, Protein kinase C: a target for anticancer 10, 389-396.
7. K. Jamil, A.P. Shaik, M. Mahboob and D. Krishna, Effect of organophosphorus and organochlorine pesticides (Monochrotophos, Chlorpyriphos, dimethoate and Endosulfan) on human lymphocytes in vitro, Drugs Chem Toxicol 27 (2004), 133-144.
8. K. Jamil, A.P. Shaik and A.J. Laxmi, Pesticide induced cytogenetic risk assessment in human lymphocyte culture in vitro Bull. Environ Contam Toxicol 75 (2005), 7-14.
9. J.W. Clark, A.H. Goroll and A.G. Mulley, Jr., Primary Care Medicine: Office Evaluation and Management of the Adult Patient. Hematologic and Oncologic Problems- Principles of Cancer Chemotherapy, Lippincott Williams & Wilkins Publishers 1328 (2006), 643.
10. K. Erjala, M. Raltanen and J. Kalmala, Reidar Grenman Concurrent use ofVinorelbine and Gefitinib induces supra-additive effect in head and neck squamous cell lines, J Cancer Res Clin Oncol 133 (2007), 169-176. (Pubitemid 46144092)
11. N. Kopjar, V. Garaj-Vrhovac and I. Milas, Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay, Teratog Carcinog Mutagen 22 (2002), 13-20.
12. M. Muller, S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S.L. Friedman, P.R. Galle, W. Stremmel, M. Oren and P.H. Krammer, p53 activates the CD95(APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs, J Exp Med(188) 11 (7 December 1998), 2033-2045.
13. M. Haber, J. Madafiglio and M.D. Norris, Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine, J Cancer Res Clin Oncol 119 (1992), 315-317.
14. Y, Mizutani, O, Yoshida, T, Miki, B. Bonavida, Synergistic cytotoxicity and apoptosis by Apo-2 ligand and Adriamycin against bladder cancer cells. Department of Urology, Faculty of Medicine, Kyoto University, Japan, Clin Cancer Res(5) 9 (Sep 1999), 2605-2612.
15. R. Naravaneni and K. Jamil, Cytogenetic biomarkers of carbofuran toxicity utilizing human lymphocyte culture in vitro, Drug Chem Toxicol 28 (2005), 359-372. (Pubitemid 41098358)
16. R. Naravaneni and K. Jamil, Evaluation of cytogenetic effects of lambda-cyhalothrin on human lymphocytes, J Biochem Mol Toxicol 19 (2005), 304-310.
17. S. Herman, N. Zurgil and M. Duetsch, LowDose Methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell to a greater extent than in monotypic lines, Inflamm Res 54 (2005), 273-280.
18. A.P. Shaik, S. Sankar, S.C. Reddy, P.G. Das and K. Jamil, Lead induced genotoxocity in lymphocytes from peripheral blood samples of humans: In vitro studies, Drug and Chemical Toxicol 75 (2005), 7-14.
19. S. Kaempf, S. Johnen, A.K. Salz and A.Weinberger, P.Walter and G. Thumann, Effects of Bevacizumab (Avastin) on Retinal Cells in Organotypic Culture, Investigative Ophthalmology and Visual Science 49 (2008), 3164-3171.
20. G. Suman and K. Jamil, Studies on combination versus single anticancer drugs in vitro, Perspectives in Cytol Gen 12 (2006), In Press.
21. G. Suman and K. Jamil, In vitro cytogenetic studies of cypermethrin on human lymphocytes, Ind J Exp Biol 44 (2006), 233-239.
22. L.M.Wiesenthal, G.J.L R.Pieters, P.R. Twenty man Cell Cultures Assays for Hematologic Neoplasms Based on the Concept of Total Tumor Cell Kill. In: Kaspers, G.J.L, R.Pieters, P.R. Twentyman, L.M. (1993).
23. Weisenthal and A.J.P. Veerman (Eds), Drugs Resistance in Leukemia and Lymphoma Langhorne P.A, Harwood Academic Publishers, pp. 415-432.
24. L.M.Weisenthal, Antineoplastic drug screening belongs in the laboratory, not in the clinic (editorial), J Natl Cancer Inst 84 (1992), 466-469.
25. L.M. Weisenthal, R.H. Shoemaker, J.A. Marsden, P.L. Dill, J.A. Baker and E.M. Moran, In vitro chemo sensitivity assay based on the concept of total tumor cell kill: Recent results, Cancer Res 94 (1984), 161-173.
26. William G. Rice, Christopher D. Hillyer, Brad Harten, Catherine A. Schaeffer, Mark Dorminy, Dixon A. Lackey III, Eva Kirsten, Jerome Mendeleyev, Kalman G. Buki, Alaeddin Hakam, and ErnestKun,. Induction of Endonuclease-mediated apoptosis in tumor cells by C-nitroso-substituted ligands of poly (ADP-ribose) polymerase, Pharmacology, Proc Natl Acad Sci USA 89 (Aug 1992), 7703-7707.
27. W. Glienke, Y. Dolgova, I. Muller, S. Grosch, J. Binder, G. Geisslinger and D. Jonas, Induction of Apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia, World J Urol 22 (2004), 452-456.
28. C.M. Zwaan, G.J.L. Kaspers, R. Pieters, N.L. Ramakers-van Woerden, M.L. den Boer, R. Wünsche et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, Blood 96 (2000), 2879-2928